Sam Carter
 | This article is a stub. |
Sam Carter (Samuel Carter) is an advocate and a patient with myalgic encephalomyelitis.
Talks and interviews[edit | edit source]
Letters[edit | edit source]
- 2010 - FINE trial for CFS. Both significant and small?[1]
- 2012 - A valedictory dispatch from the Psychosocial School?[2]
- 2016 - Exploring changes to PACE trial outcome measures using anonymised data from the FINE trial[3]
Online presence[edit | edit source]
- Website/Blog
- YouTube
See also[edit | edit source]
Learn more[edit | edit source]
- Wikipedia
References[edit | edit source]
- ↑ Carter, Sam (Jun 9, 2010). "FINE Trial for CFS: Both significant and small?". BMJ. 340: c2988. doi:10.1136/bmj.c2988. ISSN 0959-8138. PMID 20534659.
- ↑ Carter, Sam (May 5, 2012). "A valedictory dispatch from the Psychosocial School? | Rapid Responses to articles". BMJ. Retrieved Jan 29, 2019.
- ↑ Carter, Sam (Feb 15, 2016). "Exploring changes to PACE trial outcome measures using anonymised data from the FINE trial". PubMed Commons.
The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.
